Ceva
    Worldwide
    CLOSE

    Collaboration in more than 46 countries.

    You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

    Reduce your risk of Salmonella Enteriditis & Salmonella Typhimurium

     
    Vignette-685x800-Salmovac-1

    From an early age and for the lifespan of your hens

    Salmonellosis is one of the most prevalent zoonotic diseases of humans and animals in the world. 
    In 2022, Salmonellosis was the second most reported zoonotic disease in the EU, affecting 65,208 people, a 5039 increase in the absolute cases compared to previous year*.
    Controlling Salmonella in poultry production with well-established biosecurity measures and safe and efficacious vaccines such as Cevac® Salmovac is vital for companies and producers to meet social responsibilities and ensure sustainability.
    In this e-brochure you will find…
    information about these different aspects of disease management when using Cevac® Salmovac:
    Disease importance
    - Vaccination to control Salmonella effectively
    - Key vaccine features allowing disease control
    - Distinguishing between the vaccine and field isolates

    *See the latest annual European Union One Health 2022 zoonoses report by EFSA and ECDC. 
    Fill in the form and you will receive our product brochure for free!
    Poultry_Chicken_007

    What is in this manual ?

    Vignette-685x800-Salmovac-1

    📌 Maximum Protection: Advanced technology to combat contamination.

    📌 Scientifically Proven: Developed through extensive research and laboratory testing.

    📌 Easy to Use: Simple and effective application for effortless protection.

    📌 Industry-Specific Adaptation: Designed to meet the needs of sensitive sectors.

    📌 Eco-Friendly: A sustainable approach with minimal environmental impact.